Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Interest Expenses (2016 - 2022)

Arcadia Biosciences (RKDA) has disclosed Interest Expenses for 8 consecutive years, with $1000.0 as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Interest Expenses fell 88.89% year-over-year to $1000.0, compared with a TTM value of $1000.0 through Dec 2022, down 95.0%, and an annual FY2021 reading of $20000.0, down 57.45% over the prior year.
  • Interest Expenses was $1000.0 for Q1 2022 at Arcadia Biosciences, up from -$3000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $23000.0 in Q3 2020 and bottomed at -$3000.0 in Q4 2021.
  • Average Interest Expenses over 4 years is $7000.0, with a median of $4500.0 recorded in 2020.
  • The sharpest move saw Interest Expenses surged 650.0% in 2020, then tumbled 120.0% in 2021.
  • Year by year, Interest Expenses stood at $2000.0 in 2019, then soared by 650.0% to $15000.0 in 2020, then tumbled by 120.0% to -$3000.0 in 2021, then surged by 133.33% to $1000.0 in 2022.
  • Business Quant data shows Interest Expenses for RKDA at $1000.0 in Q1 2022, -$3000.0 in Q4 2021, and $15000.0 in Q3 2021.